4.6 Article

A detail survey and analysis of selectivity criteria for indole-based histone deacetylase 8 (HDAC8) inhibitors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

How the structural properties of the indole derivatives are important in kinase targeted drug design?: A case study on tyrosine kinase inhibitors

Dipayan Mondal et al.

Summary: Kinases are important signalling enzymes that make up 20% of the druggable genome. Protein kinases are responsible for regulating various cellular activities, and their deregulation can lead to diseases like cancer. Researchers are actively developing inhibitors based on different chemical scaffolds. Indole scaffold has shown to be versatile and used in the design of inhibitors against various tyrosine kinases.

BIOORGANIC & MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

RCSB Protein Data Bank: Celebrating 50 years of the PDB with new tools for understanding and visualizing biological macromolecules in 3D

Stephen K. Burley et al.

Summary: RCSB PDB, funded by several US government agencies, has been providing service to structural biologists and PDB data consumers worldwide since 1999. It is a founding member of the worldwide Protein Data Bank partnership, serving as the US data center for the global PDB archive. RCSB PDB also develops new tools and features for 3D structure analysis and visualization.

PROTEIN SCIENCE (2022)

Article Pharmacology & Pharmacy

HDAC6 as privileged target in drug discovery: A perspective

Sravani Pulya et al.

Summary: HDAC6, a class IIB HDAC isoenzyme, plays a unique role in regulating various disease states through targeting non-histone proteins. While several HDAC6 inhibitors have been developed, more work is needed to identify highly selective and potent inhibitors. Targeting HDAC6 has been found to be effective for therapeutic purposes in different disease conditions.

PHARMACOLOGICAL RESEARCH (2021)

Review Pharmacology & Pharmacy

Histone deacetylase 2 selective inhibitors: A versatile therapeutic strategy as next generation drug target in cancer therapy

Manasa Gangadhar Shetty et al.

Summary: Acetylation and deacetylation of histone and non-histone proteins are important epigenetic processes involved in cancer regulation. Abnormal expression of histone deacetylases (HDACs) is common in various cancers, but pan-HDAC inhibition may not be effective due to isoform-specific overexpression in certain cancers. Therefore, isoform-selective HDAC inhibition could be a promising therapeutic strategy against cancer.

PHARMACOLOGICAL RESEARCH (2021)

Article Chemistry, Multidisciplinary

Quantitative activity-activity relationship (QAAR) driven design to develop hydroxamate derivatives of pentanoic acids as selective HDAC8 inhibitors: synthesis, biological evaluation and binding mode of interaction studies

Sk Abdul Amin et al.

Summary: The study focused on designing pentanoic acid based hydroxamates as selective HDAC8 inhibitors, with compounds 7i and 7f identified as selective inhibitors that showed better antiproliferative activities against certain cancer cell lines and induced significant cell growth arrest in the G2/M phase. These findings suggest that these compounds could serve as lead molecules for further investigation into their anticancer potentials.

NEW JOURNAL OF CHEMISTRY (2021)

Article Chemistry, Medicinal

Design and Synthesis of Dihydroxamic Acids as HDAC6/8/10 Inhibitors

Michael Morgen et al.

CHEMMEDCHEM (2020)

Article Cell Biology

HDAC8: A Promising Therapeutic Target for Acute Myeloid Leukemia

Marco Spreafico et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Design, synthesis and activity evaluation of indole-based double - Branched HDAC1 inhibitors

Qiuqiong Zhang et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2019)

Article Chemistry, Medicinal

Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated

Magalie Geraldy et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Review Chemistry, Medicinal

Indole: A privileged scaffold for the design of anti-cancer agents

Yichao Wan et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Genetics & Heredity

Molecular characterization of HDAC8 deletions in individuals with atypical Cornelia de Lange syndrome

Maria Helgeson et al.

JOURNAL OF HUMAN GENETICS (2018)

Article Chemistry, Medicinal

Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors

Chunlong Zhao et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Chemistry, Medicinal

Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms

Sakineh Dadashpour et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4

Diana Lamaa et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Physical

First report on the structural exploration and prediction of new BPTES analogs as glutaminase inhibitors

Sk. Abdul Amin et al.

JOURNAL OF MOLECULAR STRUCTURE (2017)

Article Biochemistry & Molecular Biology

Bifunctional conjugates with potent inhibitory activity towards cyclooxygenase and histone deacetylase

Idris Raji et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2017)

Article Chemistry, Medicinal

Biphenyl-4-yl-acrylohydroxamic acids: Identification of a novel indolyl-substituted HDAC inhibitor with antitumor activity

Raffaella Cincinelli et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)

Review Chemistry, Medicinal

Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases

Alokta Chakrabarti et al.

FUTURE MEDICINAL CHEMISTRY (2016)

Article Biochemistry & Molecular Biology

Structure of 'linkerless' hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket

Alexa A. Tabackman et al.

JOURNAL OF STRUCTURAL BIOLOGY (2016)

Article Biochemistry & Molecular Biology

Variable Active Site Loop Conformations Accommodate the Binding of Macrocyclic Largazole Analogues to HDAC8

Christophe Decroos et al.

BIOCHEMISTRY (2015)

Article Chemistry, Medicinal

Development of 3-hydroxycinnamamide-based HDAC inhibitors with potent in vitro and in vivo anti-tumor activity

Xiaoyang Li et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Cell Biology

Erasers of Histone Acetylation: The Histone Deacetylase Enzymes

Edward Seto et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)

Article Gastroenterology & Hepatology

The Up-Regulation of Histone Deacetylase 8 Promotes Proliferation and Inhibits Apoptosis in Hepatocellular Carcinoma

Jian Wu et al.

DIGESTIVE DISEASES AND SCIENCES (2013)

Article Chemistry, Medicinal

A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold

Melissa M. Kemp et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Article Chemistry, Multidisciplinary

PaDEL-Descriptor: An Open Source Software to Calculate Molecular Descriptors and Fingerprints

Chun Wei Yap

JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222

Stefania Terracciano et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2010)

Article Chemistry, Medicinal

Non-Natural Macrocyclic Inhibitors of Histone Deacetylases: Design, Synthesis, and Activity

Luciana Auzzas et al.

JOURNAL OF MEDICINAL CHEMISTRY (2010)

Article Chemistry, Medicinal

Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors

David V. Smil et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)

Article Chemistry, Medicinal

A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo

Philip Jones et al.

JOURNAL OF MEDICINAL CHEMISTRY (2008)

Article Chemistry, Medicinal

Novel aminophenyl benzamide-type histone deacetylase inhibitors with enhanced potency and selectivity

Oscar M. Moradei et al.

JOURNAL OF MEDICINAL CHEMISTRY (2007)

Article Biochemistry & Molecular Biology

Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex

Alessandro Vannini et al.

EMBO REPORTS (2007)

Article Chemistry, Medicinal

A series of novel, potent, and selective histone deacetylase inhibitors

Philip Jones et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)

Article Biochemistry & Molecular Biology

Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases

JR Somoza et al.

STRUCTURE (2004)

Article Biochemistry & Molecular Biology

Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A

H Lee et al.

MOLECULAR AND CELLULAR BIOLOGY (2004)

Article Multidisciplinary Sciences

Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor

A Vannini et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Biochemistry & Molecular Biology

Cloning and characterization of a novel human. Class I histone deacetylase that functions as a transcription repressor

E Hu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)